Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection

Myasthenia gravis (MG) is an autoimmune neuromuscular transmission disorder characterized by loss of acetylcholine receptors (AChR’s) due primarily to the production of anti-AChR autoantibodies. In this study we investigated whether the presence of decay-accelerating factor (DAF or CD55), an intrins...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Clin Invest
Autors principals:	Lin, Feng, Kaminski, Henry J., Conti-Fine, Bianca M., Wang, Wei, Richmonds, Chelliah, Medof, M. Edward
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Clinical Investigation 2002
Matèries:	Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151616/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12417565/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI16086
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!